Bristol Myers Squibb to Report Results for Third Quarter 2023 on October 26, 2023

Rhea-AI Impact
Rhea-AI Sentiment
conferences earnings
Rhea-AI Summary
Bristol Myers Squibb (BMY) will announce Q3 2023 results on October 26, 2023. Investors can join the conference call and webcast. Materials available at Replay available until November 9, 2023.
  • None.
  • None.

PRINCETON, N.J.--(BUSINESS WIRE)-- Bristol Myers Squibb (NYSE: BMY) will announce results for the third quarter of 2023 on Thursday, October 26, 2023. Company executives will review financial results and address inquiries from investors and analysts during a conference call beginning at 8:00 a.m. ET on the same date.

Investors and the general public are invited to listen to a live webcast of the call at Investors and the public can register for the live conference call here. Those unable to register can access the live conference call by dialing in the U.S. toll free 1-833-816-1116 or international +1 412-317-0705. Materials related to the call will be available at prior to the start of the conference call.

A replay of the webcast will be available at approximately three hours after the conference call concludes. A replay of the conference call will be available beginning at 11:30 a.m. ET on October 26, 2023, through 11:30 a.m. ET on November 9, 2023, by dialing in the U.S. toll free 1-877-344-7529 or international +1 412-317-0088, conference code: 3515954.

About Bristol Myers Squibb

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram.




Source: Bristol Myers Squibb

Bristol-Myers Squibb Co.


BMY Rankings

BMY Latest News

BMY Stock Data

Pharmaceutical Preparation Manufacturing
Health Technology, Pharmaceuticals: Major, Manufacturing, Pharmaceutical Preparation Manufacturing
New York

About BMY

The Bristol-Myers Squibb Company is an American multinational pharmaceutical company. Headquartered in New York City, BMS is one of the worlds largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations. For fiscal 2022, it had a total revenue of $46.2 billion.